Yamaguchi S, Baba Y, Naito K
Department of Urology, Shuto General Hospital.
Hinyokika Kiyo. 1997 Sep;43(9):641-5.
Between August 1995 and June 1996, a total of eighty Japanese men underwent ultrasound guided systematic biopsy of the prostate. Sixty-six men were clinically suspected of having prostatic cancer by elevated serum PSA (Tandem-R kit) value or digital rectal examination (DRE). Overall, 63 of the 80 (78.8%) men had elevated serum PSA with normal DRE and 30 of the 80 men (37.5%) had prostatic cancer. In patients with PSA values of 0 to 4.0 ng/ml, 4.1 to 10.0 ng/ml and 10.1 ng/ml or more, the positive predictive value of PSA was 33.3%, 23.3% and 66.7%, respectively. In patients with PSA levels of 4.1-10.0 ng/ml, the positive predictive values of digital rectal examination, transrectal ultrasonography and PSA density were 30.0%, 28.0% and 31.8%, and the false-negative rates were 20.0%, 0% and 0%, respectively. Along with the findings of transrectal ultrasonography and PSA density, estimation of PSA value and abnormal findings of digital rectal examination may help minimize the number of biopsies in patients with PSA values of 4.1-10.0 ng/ml. Systematic biopsies were performed without major complications. The biopsy missed the cancer in 4.6%.
1995年8月至1996年6月期间,共有80名日本男性接受了超声引导下的前列腺系统活检。66名男性因血清前列腺特异抗原(Tandem - R试剂盒)值升高或直肠指检(DRE)而临床上怀疑患有前列腺癌。总体而言,80名男性中有63名(78.8%)血清前列腺特异抗原升高而直肠指检正常,80名男性中有30名(37.5%)患有前列腺癌。在前列腺特异抗原值为0至4.0 ng/ml、4.1至10.0 ng/ml以及10.1 ng/ml及以上的患者中,前列腺特异抗原的阳性预测值分别为33.3%、23.3%和66.7%。在前列腺特异抗原水平为4.1 - 10.0 ng/ml的患者中,直肠指检、经直肠超声检查和前列腺特异抗原密度的阳性预测值分别为30.0%、28.0%和31.8%,假阴性率分别为20.0%、0%和0%。结合经直肠超声检查和前列腺特异抗原密度的结果,前列腺特异抗原值的评估以及直肠指检的异常发现可能有助于减少前列腺特异抗原值为4.1 - 10.0 ng/ml患者的活检次数。系统活检未出现重大并发症。活检漏诊癌症的比例为4.6%。